From Paul Obiajunwo, Port Harcourt
Production of syringes at the Integrated Medical Industries (IMI) in Port Harcourt, Rivers State is expected to hit 1.3 billion in 2014, up from the current 160 million syringes per year.
Chairman of the IMI and Rivers Health Commissioner, Dr. Tamunoiyoriari Sampson Parker, who disclosed this on Wednesday, said the projected increase would be achieved on completion of the ongoing $27m upgrade at the firm.
Parker, who made the disclosure in Vienna, Austria at the first test run of the IMI Power Plant built by G E Jenbacher GMBH & Co, a subsidiary of General Electric said: “Oil has been good to the Rivers People, but Governor Amaechi believes the best way to sustain development of the State is to stimulate added economy independent of oil.”
“That is why the State Government has invested heavily on manufacturing, farming, education, health and energy,” he added.
According to Parker, would provide 14 megawatts of electricity to IMI and the manufacturing plants in Port Harcourt with the boost in production also resulting in 1 billion hypodermic needles, 105 million IV giving sets, and 90 million IV solutions per annum aside the syringe production.
The medical firm, Parker noted, is jointly owned by the Rivers State and the Federal Government, but currently financed wholly by the Rivers State Government.
“The IMI is the first manufacturer of medical equipment in sub-Saharan Africa and the 18th in the world to win the converted World Health Organization PQS, which is the highest standard in the world,” Parker said.